Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News OncoCell MDx raises $22.2m for liquid biopsy immunogenomics platform OncoCell MDx, a Michigan-based immugenomics platform company, which is focused on developing noninvasive blood-based diagnostic tests, has secured… bypharmanewsdailySeptember 17, 2019